–
/ By Alan Gallindoss/
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
On June 12th Jewish Business News reported that Teva had settled a major lawsuit brought against it by Pfizer and would be taking a charge again against earnings of approximately US$ 930 million in the second quarter of 2013, additional to US$ 670 million in provisions already made. We also reported that Teva stated that it believed it may have up to US$ 560 million in net insurance coverage with respect to this settlement which it may be able to recover from its insurance carriers.
In making that statement Teva obviously was a little tentative, and now we know why as their insurer Illinois Union Insurance is apparently claiming that it does not have to cover the payout, and is now even suing Teva in the US District Court for the Eastern District of Pennsylvania claiming that it does not have to cover the payout on the grounds that it was never properly notified of the suit.
Markets have already seemed to absorb this possible outcome and moved on, and Teva’s shares hardly moved with the news:
Teva NYSE US$
Source: company website
